Trending News

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

BREAKING: District Court Restores Status Quo Ante At NLRB

Update: Federal Judge Reinstates National Labor Relations Board (NLRB) Member (US)

Virginia Poised to Become Second State to Enact Comprehensive AI Legislation

Michigan Federal Court Holds CTA Reporting Rule Unconstitutional, Enjoins Enforcement Against Named Plaintiffs

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights
Posted On Monday, March 31, 2025
Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
Posted On Monday, March 31, 2025
Revolution Medicines to Participate in April 2025 Investor Conferences
Posted On Monday, March 31, 2025
Reviva Reports Full Year 2024 Financial Results and Recent Business Highlights
Posted On Monday, March 31, 2025
Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
Posted On Monday, March 31, 2025
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights
Posted On Monday, March 31, 2025
Aruna’s Co-Founder and Chief Scientific Officer, Dr. Steven Stice, Inducted into the 2025 Class of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows
Posted On Monday, March 31, 2025
Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update
Posted On Monday, March 31, 2025
Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates
Posted On Monday, March 31, 2025
Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings
Posted On Monday, March 31, 2025
Adverum Biotechnologies to Participate in the 2025 RBC Capital Markets Ophthalmology Virtual Conference
Posted On Monday, March 31, 2025
Ascendis Submits U.S. NDA for TransCon CNP (Navepegritide) for the Treatment of Children with Achondroplasia
Posted On Monday, March 31, 2025
Cytokinetics to Participate in the 24th Annual Needham Virtual Healthcare Conference
Posted On Monday, March 31, 2025
Dogwood Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results
Posted On Monday, March 31, 2025
Radiance Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of RB-164™, an ROR-1 Targeted ADC, for Hematologic and Solid Malignancies
Posted On Monday, March 31, 2025
Marker Therapeutics Reports Year-End 2024 Corporate and Financial Results
Posted On Monday, March 31, 2025
ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024
Posted On Monday, March 31, 2025
Actor and Comedian Kenan Thompson Teams Up with Phathom Pharmaceuticals to Raise Awareness About GERD and VOQUEZNA® (vonoprazan)
Posted On Monday, March 31, 2025
SAB BIO Reports Full Year 2024 Operating and Financial Results
Posted On Monday, March 31, 2025
Ocular Therapeutix™ to Participate in Two Investor Conferences in April
Posted On Monday, March 31, 2025
Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD™ 2025
Posted On Monday, March 31, 2025
Gyre Therapeutics Announces NMPA Approval for Clinical Trial Evaluating Pirfenidone Capsules in Oncology-Related Pulmonary Complications
Posted On Monday, March 31, 2025
TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery
Posted On Monday, March 31, 2025
Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Posted On Monday, March 31, 2025
Atavistik Bio Announces Appointment of William Sellers, M.D. to its Scientific Advisory Board
Posted On Monday, March 31, 2025

Print